Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 1,604,069	$ 890,152
Cost of goods sold	1,770,552	691,843
Gross (loss) profit	(166,483)	198,309
Operating expenses:
Research and development	1,920,548	714,281
Sales and marketing	1,415,282	1,300,120
General and administrative	6,603,935	6,678,310
Total operating expenses	9,939,765	8,692,711
Loss from operations	(10,106,248)	(8,494,402)
Other (expense) income:
Other income	236,923	2,188
Interest expense	(327,196)	(172,479)
Loss on extinguishment of debt	(566,925)
Total other expense, net	(657,198)	(170,291)
Net loss	(10,763,446)	(8,664,693)
Deemed dividend on modification of Series H-5 warrants	(432,727)
Net loss attributable to Common Stockholders	$ (11,196,173)	$ (8,664,693)
Net loss per share, basic and diluted	$ (0.73)	$ (2.95)
Basic and diluted weighted average Common Stock outstanding	15,336,617	2,940,975